|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Audentes Therapeutics Inc.
| | | Phone: | (415) 638-6556 | Year Established: | 2012 | Ticker: | BOLD | Exchange: | NASDAQ | Main Contact: | Matthew R. Patterson, President, CEO & Co-Founder | | Other Contacts: | Natalie Holles, Senior VP & COO Thomas Soloway, Senior VP & CFO Mary Newman, Senior VP, RA John Gray, Ph.D., VP, R&D Monica Miller, VP, Program & Alliance Management Barbara Wuebbels, RN, VP, Patient Advocacy Suyash Prasad, MD, Senior VP & CMO Michael O’Callaghan, DVM, Ph.D., Senior VP, Preclinical Development & Translational Medicine
| | Company Description | Audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious, rare muscle diseases through the application of adeno-associated virus (AAV) gene therapy technology. The company consists of a focused, experienced, and passionate team driven by the goal of improving the lives of patients. | |
|
|
|
|
|